09.23.08
Tris Pharma has completed the expansion of its research and manufacturing facility in South Brunswick, NJ. The expansion provides 15,000 sq. ft. of additional space to the facility and is FDA-compliant with cGMP. It allows for additional commercial-scale equipment and a new, larger warehouse with a high-speed packaging area.
"These recent events show that the company is on a steady and stable path as charted," says Ketan Mehta, chief executive officer and founder of Tris Pharma. "FDA's assurance of our facilities and the recent investment in our capabilities mean we have ample infrastructure with which to leverage our pipeline of drug delivery technologies and services."
"These recent events show that the company is on a steady and stable path as charted," says Ketan Mehta, chief executive officer and founder of Tris Pharma. "FDA's assurance of our facilities and the recent investment in our capabilities mean we have ample infrastructure with which to leverage our pipeline of drug delivery technologies and services."